Background: Viral hepatitis is a global health problem with 170 million Hepatitis C Virus (HCV) carriers worldwide, and 12-13 million HCV carriers in India. Unscreened blood and components play a significant role in transmission of HCV apart from reuse of injection needles, unsterilized surgical equipments and vertical transmission from mother to child. Unsafe blood transfusion not only poses risk to patients, causing significant morbidity and mortality, but also adds to the economical burden on healthcare system. Aims and Objectives: Aim of this study is to estimate the seroprevalence of HCV infection among the voluntary and relative donors over a period of 7 years at blood banks of Madhya Pradesh with collaboration of Madhya Pradesh State AIDS control Society (MPSACS) Bhopal, India from 2011 to 2017. Materials and Methods: This is a retrospective study of blood donation at blood banks, of Madhya Gupta et al.; IBRR, 9(3): 1-8, 2019; Article no.IBRR.49800 2 Pradesh, India. Blood units were screened for TTIs from January 2011 To December 2017. HIV, HCV and HBV tests were done by ELISA. Data of HCV was collected and compared statistically by frequency distribution and percentage proportion. Chi Square (χ 2) test was used to determine the significant difference statistically. Results: The mean age of donors was 32.4 2 ± 8.63 years. Major contribution was from male donors (93.8%). Majority of donation was done voluntarily (87.3 %). Out of the total 1,876,219 donors tested for TTIs over 7 years, 1980 (0.11%) were positive to anti HCV (p=.000001).
INTRODUCTION
Increasing incidence of viral hepatitis is posing a threat to healthcare in India, almost comparable to the three major communicable diseases i.e. HIV/AIDS, malaria and tuberculosis [1] . Out of the five hepatitis causing viruses, Hepatitis B virus (HBV) and Hepatitis C virus (HCV) have parenteral transmission and are known to cause chronic hepatitis, cirrhosis of liver and hepatocellular carcinoma (HCC). Around 400 million people all over the world suffer from chronic hepatitis and the Asia-Pacific region constitutes the epicenter of this epidemic [1] .
The prevalence of HCV infection varies worldwide and the most affected regions are WHO Eastern Mediterranean and European Regions, with the prevalence of 2.3% and 1.5% respectively. Prevalence of HCV infection in other WHO regions varies from 0.5% to 1.0% [2] . In India, prevalence of HCV infection in general population is estimated to be around 0.5%-1.5% [3] . The seroprevalence rate of HCV among the blood donors in India is 0.53 to 5.1% [4] .
HCV is a single-stranded hepatotropic RNA virus of family Flaviviridae. HCV causes acute hepatitis which is mostly subclinical and gradually evolves into chronic hepatitis in about 80% of those infected [5] . HCV has six major genotypes, with genotype 1 being the most prevalent genotype globally (46%), followed by genotype 3 in 22% and genotypes 2 and 4 in 13% each. [6] Overall, genotype [3] is the predominant genotype (63.85%) followed by genotype 1 (25.72%) in India [7] .
Unscreened blood and components play a significant role in transmission of HCV apart from reuse of injection needles, unsterilized surgical equipments and vertical transmission from mother to child [8] . Unsafe blood transfusion not only poses a risk to patient, causing significant morbidity and mortality, but also adds to the economical burden on healthcare system. Thus National AIDS Control organization (NACO) of India mandates to screen every unit of blood and components for 5 transfusion transmitted infections (TTIs) i.e. HIV, HCV, HbsAg, Syphilis and Malaria [9] .
The methods used to identify the presence of HCV employ the following screening targets: 
HCV
antibody becomes detectable approximately 30 to 60 days after infection. Viral RNA appears followed by viral antigen between 0 and 20 days. Antibody can be detected between 10 and 40 days after antigen is first detected. Hepatitis C virus RNA is normally detectable within a few weeks of infection and persists for 6-8 weeks prior to antibody seroconversion. The detection of HCV RNA may further reduce the risk of HCV transmission through the transfusion of infected blood donated during the window period of antigen and antibody assays. However, any benefit is dependent upon HCV incidence and the actual number of donations that may be collected in the window period [10] . 
MATERIALS AND METHODS
Place of work: Present study was carried out at National AIDS Control Organization (NACO) supported blood banks and MPSACS (Madhya Pradesh State Aids Control Society) Bhopal, Madhya Pradesh, India. Donors were screened by trained personnel after satisfactory answering the donor's questionnaire, their physical examination and hemoglobin (Hb %) estimation.
Sample size and study duration: A total of 1,876,219 blood units from the selected donors were collected during the period of 7 years (1st January 2011 to 31st December 2017). 
RESULTS
Blood from 1,876,219 apparently healthy donors aging 18 -65 years was collected during the study period. Increasing trend in blood donation was reported from the year 2011 to 2017, depicted in Fig. 1 and increasing pattern of voluntary blood donation is shown in Table 2 , which was steady and was found to be statistically insignificant (p value= 0.94). District wise prevalence of HCV infection among blood donors and geographical distribution in state of Madhya Pradesh is shown in Table 4 and Fig. 2 
DISCUSSION
The current study is conducted in sequence of a larger study conducted in 2018, elaborating the incidence of various transfusion transmitted infections (TTIs) in state of Madhya Pradesh. [11] A need of research upon individual TTIs i.e. HIV, HBV, HCV, syphilis and malaria arose which led to publication of trends of HIV and HBV in 2018, and continuing the process, the present study on HCV infection.
A slight difference was noted with respect to HCV reactivity in males and females. Males showed slightly higher HCV reactivity possibly attributed to more propensities for high risk behavior. However the difference was not found to be statistically significant similar to result of study by Makroo et al (2015) . [12] Voluntary blood donor showed slightly lesser HCV reactivity than relative/exchange donor because, voluntary blood donors are more likely to answer the questionnaire honestly in contrast to relative/exchange donors, who because of dire need and urgency of requirement of blood for the patient are more likely to hide the fact of high risk behavior. This has been advocated by WHO stating that "The safest blood donors are voluntary, non-remunerated blood donors from low-risk populations" [13, 14] .
In the current study, we observed a steady increase in voluntary blood donation with an average of 87. In the United States seroprevalence in HCV of blood donors was estimated to be 0.3 percent. [22] In Greece also, a low prevalence (0.2 to 0.4%) of antibodies to HCV has been reported and a similarly low rate (0.13%) was also reported from Iran. Lower rates of anti-HCV antibodies have also been reported in blood donors of Turkey (0.07%), Saudi Arabia (0.4%), Mexico (0.84%) and Kenya (0.9%). [22] HCV is globally distributed, with anti-HCV prevalence among donors ranging from 0.3 to 0.5% throughout the world. [18] Prevalence of HCV in blood donors calculated in our study is found to be lower than most other incidence studies all over India (0.11% vs. 0.53 to 5.1%). [4] The low prevalence of HCV in blood donors in Madhya Pradesh was may be due to proper screening of donors and strict follow up of donor questionnaire which eliminated the high risk donors. When analyzed year wise, a decrease in HCV reactivity among blood donors was reported from 2014 to 2015. This change was attributed to proper donor selection with counseling and filing up of questionnaire. In 2017 a slight increase was noted in HCV incidence which most likely occurred due to introduction of advanced technique for detection which curtail the false negative results observed in the window period and increased sensitivity.
In the 4 districts where HCV reactivity was reported to be more than 0.2%, which may be possible due to prominent tribal rural population with limited health awareness [23] .
HCV transmission is attributed to high risk sexual behavior, unsafe healthcare practices like reuse of needles and unsterilized equipments, and transfusion of unscreened blood and blood products. Safe medical practices and public awareness, and concept of safe blood components to the patients can curb the transmission of HCV and TTIs.
CONCLUSION
It can be concluded that there is an increasing trend in blood donation specifically voluntary blood donation with a male predominance. It can also be seen from the above data that there is a strategic fall in the prevalence of HCV infection from 2008-2017 which is due to the various awareness, educational programs and campaigns run by the Government of India. Introduction of more specific and highly sensitive tests like NAT (Nucleic acid amplification testing) in transfusion services in India is the need of hour.
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